Abstract:Objective: To provide updated guidance on pre-conception folic acid and multivitamin supplementation for primary and secondary (recurrence) prevention of neural tube defects and other folate-sensitive congenital anomalies. Target population: Women aged 12-45 years who could become pregnant should be aware of the risk of serious birth defects without adequate pre-conception and first-trimester folic acid supplementation. Options: Optimizing folic acid supplementation is complex and depends on factors including dosage; type of supplement; bioavailability of folate from food, timing of initiating supplementation; and metabolic and genetic factors. For all women who could become pregnant, a low daily dosage of folic acid is recommended before conception and throughout pregnancy and breastfeeding. High-dosage folic acid supplementation is recommended only for women who can become pregnant and have had a previous pregnancy affected by a neural tube defect or other folate-sensitive congenital anomaly. Directed personalized approaches could be considered and adopted for women who can become pregnant and have complex risks (genetic, medical, or surgical risk factors), using new knowledge of co-factor metabolism and synergy, as well as red blood cell or serum folate testing. Such approaches would require changes to current provincial health care maternal serum folate screening/testing. Outcomes: New approaches to oral folic acid supplementation, including triage tools, need to be considered to optimize the benefits of decreasing risk of neural tube defects and folate-sensitive congenital anomalies. Benefits, harms, and costs: Oral folic acid supplementation, or dietary folate intake combined with a multivitamin/micronutrient supplement, is associated with lower rates of neural tube defects, other folate-sensitive birth defects, and obstetrical complications. The costs are those attributable to daily vitamin supplementation and a healthy, folate-rich diet. Evidence: A literature search was designed and carried in PubMed and the Cochrane Library databases from 1990 to 2021 using following MeSH terms and keywords (and variants): folic acid supplementation; folate food fortification; primary neural tube defect prevention; prevention of recurrence of neural tube defects; folate-sensitive birth defects; folate supplementation benefit; folate supplementation risk; folate pregnant woman physiology; pregnant woman RBC folate level; pregnant woman serum folate levels; folate and epilepsy; folate and obesity. This guideline was based upon expert guidelines or opinions, systematic reviews, randomized controlled clinical trials, and observational case-control studies and case series retrieved, published in English from 1990 to 2021. Validation methods: The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix A (Tables A1 for definitions and A2 for interpretations of strong and weak recommendations). Intended audience: Maternity health care providers (physicians, midwives, nurses) and other providers of pregnancy-related wellness and health counselling. Summary statements: RECOMMENDATIONS.

Periconceptional folic acid and risk for neural tube defects among higher risk pregnancies.

Effects of Folic Acid Supplementation During Different Pregnancy Periods and Relationship with the Other Primary Prevention Measures to Neural Tube Defects

Maternal body mass index and the association between folic acid supplements and neural tube defects.

Periconceptional Factors Affect the Risk of Neural Tube Defects in Offspring: a Hospital-Based Case-Control Study in China.

Periconceptional Folic Acid Use Prevents Both Rare and Common Neural Tube Defects in China

Optimization of folic acid supplementation in the prevention of neural tube defects

Folic Acid Supplementation to Prevent Neural Tube Defects: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Nausea and Vomiting in Early Pregnancy and the Risk of Neural Tube Defects: a Case-Control Study.

Modeling the impact of folic acid fortification and supplementation on red blood cell folate concentrations and predicted neural tube defect risk in the United States: have we reached optimal prevention?

Guideline No. 427: Folic Acid and Multivitamin Supplementation for Prevention of Folic Acid-Sensitive Congenital Anomalies

[Maternal periconceptional folic acid supplementation and its effects on the prevalence of fetal neural tube defects].

Periconceptional Folic Acid Use and Its Effects on Neural Tube Defects — Five Counties, Shanxi Province, China, 2010–2016

The concept of folic acid supplementation and its role in prevention of neural tube defect among pregnant women: PRISMA

Pre-conception folic acid and multivitamin supplementation for the prevention of Neural Tube Defect: An umbrella Review

Effect of Periconceptional Folic Acid Supplementation on the Risk of Neural Tube Defects Associated with a Previous Spontaneous Abortion or Maternal First-Trimester Fever

Prevention of Neural-Tube Defects With Folic Acid in China

Blood folate level needed for fully effective neural tube defect prevention

Gestational Folate and Folic Acid Intake among Women in Canada at Higher Risk of Pre-Eclampsia

Initiation and duration of folic acid supplementation in preventing congenital malformations

High Ratios Of C20:4n-6/C20:5n-3 And Thromboxane B-2/6-Keto-Prostaglandin F-1 Alpha In Placenta Are Potential Risk Contributors For Neural Tube Defects: A Case-Control Study In Shanxi Province, China

Plasma folate levels and associated factors in women planning to become pregnant in a population with high prevalence of neural tube defects.